Oxford Nanopore Technologies plc develops and commercializes a technology platform using nanopore-based sensing for the analysis of various types of molecules. The company offers MinION, a portable device for deoxyribonucleic acid and ribonucleic acid sequencing; GridION, a self-contained benchtop device for running and analyzing up to five MinION or Flongle flow cells; MinION Mk1C for basecalling and data analysis, touchscreen operation, and wireless connectivity; Flongle, an adapter for use in MinION or GridION devices to attach a Flongle flow cell; GridION Mk1, a benchtop nanopore sequencer; PromethION 2 Solo and PromethION 2, a low-cost access to high-yield PromethION sequencing; PromethION 24 and PromethION 48 benchtop nanopore-based sequencers for multiple users to deliver multi-sample and multi-experiment sequencing results; and VolTRAX, an USB-powered device, which automates laboratory processes upstream of nanopore sequencing. It also provides MinKNOW, a software that offers data acquisition, real-time analysis and feedback, local basecalling, and data streaming; Basecalling tools to determine the identity and order of bases on the DNA/RNA molecule; EPI2ME, a cloud-based data analysis platform for end-to-end analysis of nanopore data in real time; and EPI2ME Labs, a bioinformatics solution to assist users in developing their skills and confidence in the analysis of their nanopore-based sequencing data. In addition, the company is developing MinION Mk1D; Ubi; Plongle; and SmidgION products. It sells its products online. The company was formerly known as Oxford NanoLabs Limited and changed its name to Oxford Nanopore Technologies Limited in May 2008. Oxford Nanopore Technologies plc was incorporated in 2005 and is based in Oxford, the United Kingdom.

Hagan Bayley

Gordon Sanghera

Spike Willcocks

Oxford Nanopore Technologies plc

Massive Bioinformatics provides bioinformatics and biotechnology solutions aimed at enhancing the quality of life through innovative products and services, self-described as a team of dedicated scientists and software engineers.

Massive Bioinformatics

Princeton Scientific Corp. provides material science and engineering related products, including high-purity single crystals and substrates, as well as particle beam line technology for research and industrial applications.

Metric
Company Name	Oxford Nanopore Technologies plc	Massive Bioinformatics	Princeton Scientific Corp.
Symbol	ONT
MSH ID	COM:NANOPORETECH	COM:MASSIVEBIOINFORMATICS	COM:PRINCETONSCIENTIFIC
Market	STOCKS	PRIVATE	PRIVATE
Sector	Healthcare	Healthcare & Health Services	Technology
Industry	Biotechnology	Biotechnology	Materials Science
Country	GB	TR	US
Stage
Employee Count	1.24K
Website	nanoporetech.com	massivebioinformatics.com	princetonscientific.com
LinkedIn			princeton-scientific-corp
Founders

Metric
Market Cap	11.27M
Enterprise Value
Monthly Web Traffic		833
Web Traffic Growth		0.18
Valuation
Raised Capital

Metric
Revenue	216.19M
Revenue (LTM)
Revenue (NTM)
Gross Profit	115.29M
EBITDA	-161.80M
Operating Income	-214.84M
Net Income	-196.88M
EPS	-0.24
Diluted EPS	-0.24
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin	0.56
Operating Profit Margin	-0.97
EBITDA Margin	-0.75
Net Profit Margin	-0.87
Return on Equity	-0.33
Return on Assets	-0.28
Return on Capital Employed	-0.35

COM:NANOPORETECH

Oxford Nanopore Technologies plc

Last Close

128.80

25/11 09:23

Market Cap

8.84M

Beta: -

Volume Today

162.82K

Avg: -

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio	-14.16
P/B Ratio	1.86
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio	6.54
EV Multiple	-4.58

Metric
Days Sales Outstanding
Days Payables Outstanding	112.75
Days Inventory Outstanding	399.41
Operating Cycle	505.75
Cash Conversion Cycle	324.33
Asset Turnover	0.41

Metric
Operating Cash Flow	-156.18M
Free Cash Flow	-188.58M
Cash Flow to Debt	-4.59
Operating Cash Flow/Sales	-0.69
Free Cash Flow Yield	-0.07

Metric
Cash & Equivalents	281.01M
Accounts Receivable	150.36K
Inventory	129.39M
Goodwill
Debt to Capitalization	0.06
Debt to Assets	0.04
Current Ratio	6.22
Quick Ratio	3.87

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue	0.25
R&D to Revenue	0.33
SG&A to Revenue	0.79